Need help finding what you are looking for?
Contact Us
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1498761
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1498761
PCR-based Infectious Diseases Market, By Disease Type, By Application, By End User, By Technology, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
PUBLISHED:
PAGES: 316 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
REPORT HIGHLIGHT
PCR-based Infectious Diseases Market size was valued at USD 4,790.32 million in 2023, expanding at a CAGR of 6.91% from 2024 to 2032.
The PCR-based infectious diseases market refers to the segment of the healthcare industry focused on diagnostic techniques that utilize Polymerase Chain Reaction (PCR) technology to identify pathogens responsible for infectious diseases. PCR is a molecular biology technique used to amplify DNA segments, making it a powerful tool for detecting the presence of viruses, bacteria, fungi, and other pathogens in clinical samples. The market has been experiencing steady growth due to several factors, including the increasing incidence of infectious diseases, advancements in PCR technology, growing demand for rapid and accurate diagnostic techniques, and rising healthcare expenditure. There is a growing trend towards the adoption of PCR-based POCT devices, which enable rapid and decentralized testing, particularly in resource-limited settings and for outbreak management.
PCR-based Infectious Diseases Market- Market Dynamics
Increasing Trend Toward the Adoption of PCR-based POCT Devices
PCR-based POCT devices offer rapid and accurate results, often within minutes, allowing for quick diagnosis and timely intervention. This is especially crucial in settings where immediate decisions need to be made regarding patient care. Many PCR-based POCT devices are integrated with digital health technologies, such as smartphone apps or cloud-based platforms, enabling real-time data analysis, remote monitoring, and seamless communication between healthcare providers and patients. According to the World Health Organization (WHO), the human immunodeficiency virus (HIV) is the source of the chronic infectious illness AIDS. World Health Organization (WHO) estimates for 2021 show that 0.65 million individuals died from HIV-related causes and that 38.4 million people worldwide were still living with the virus.
PCR-based Infectious Diseases Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.91% over the forecast period (2024-2032)
Based on disease type segmentation, viral diseases were predicted to show maximum market share in the year 2023
Based on application segmentation, Clinical diagnostics was the leading type in 2023
Based on end-user segmentation, Hospitals & Clinics was the leading type in 2023
Based on region, North America was the leading revenue generator in 2023
PCR-based Infectious Diseases Market- Segmentation Analysis:
The Global PCR-based Infectious Diseases Market is segmented on the basis of Disease Type, Application, End User, Technology, and Region.
The market is divided into four categories based on end-users: Hospitals & Clinics, Diagnostic Laboratories, Research Institutes, and Pharmaceutical & Biotechnology Companies. Hospitals make up the biggest end-user segment. The main healthcare facilities that conduct a variety of diagnostic tests, such as PCR molecular diagnostics, are hospitals. In hospitals, PCR technology is essential for the precise and prompt identification of a wide range of illnesses. The requirement for quick and accurate diagnostic tests to inform therapy and patient management choices is what drives the demand for PCR molecular diagnostics in hospitals.
The market is divided into two categories based on application: Clinical diagnostics, Research applications, and Epidemiological studies. Clinical diagnostics is the largest segment. PCR-based infectious disease testing is essential for detecting and tracking a wide range of pathogens, such as bacteria, viruses, and fungi. The need for PCR-based infectious disease testing is driven by the prevalence of infectious diseases, including respiratory infections, STDs, and infections linked to healthcare, around the world.
PCR-based Infectious Diseases Market- Geographical Insights
North America region tends to have a significant market share due to well-established healthcare infrastructure, high healthcare expenditure, and early adoption of advanced diagnostic technologies like PCR. The United States and Canada are key contributors to this market. Regulatory frameworks and healthcare policies can vary between different states and provinces, influencing market dynamics. For example, differences in reimbursement policies or regulatory approvals can impact the adoption and penetration of PCR-based diagnostics. Countries in Europe also have a considerable market share owing to advanced healthcare systems and a high prevalence of infectious diseases. Countries like Germany, the UK, France, and Italy are major markets for PCR-based infectious disease diagnostics.
PCR-based Infectious Diseases Market- Competitive Landscape:
The market is characterized by the presence of several key players, including biotechnology and diagnostic companies, academic research institutions, and healthcare organizations. Major players in PCR-based Infectious Diseases include Abbott Laboratories, Takara Bio, Inc, Thermo Fisher Scientific, Qiagen N.V., Roche Diagnostics etc. These players compete through product innovation, strategic collaborations, and geographical expansion. Roche is a major player in the PCR-based diagnostics market, offering a wide range of PCR-based tests for infectious diseases, including HIV, hepatitis, and respiratory infections. Thermo Fisher provides a broad portfolio of PCR-based products and solutions for infectious disease testing, including assays for COVID-19, respiratory infections, and sexually transmitted infections. Qiagen offers a range of PCR-based assays and sample preparation technologies for infectious disease testing, including tests for respiratory infections, gastrointestinal infections, and sexually transmitted infections.
Recent Developments:
In September 2022, Minute Molecular Diagnostics, a Northwestern University spinoff created a quick polymerase chain reaction (PCR) test for COVID-19. The researchers are employing Minute Molecular's DASH Analyzer, a small, portable device that offers easy-to-read results in around 15 minutes, to create a quick PCR test.
In August 2021, QIAGEN and GT Molecular collaborated to proposal a complete SARS-CoV-2 wastewater recognition resolution based on QIAcuity Digital PCR innovation.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PCR-BASED INFECTIOUS DISEASES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Abbott Laboratories
Takara Bio, Inc
Thermo Fisher Scientific
Qiagen N.V.
Bio-Rad Laboratories, Inc
Roche Diagnostics
Cepheid
DiaSorin
Others
GLOBAL PCR-BASED INFECTIOUS DISEASES MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019 - 2032
- Viral diseases
- HIV
- hepatitis
- influenza
- Bacterial diseases
- tuberculosis
- MRSA
- Fungal infections
- candidiasis
- Parasitic infections
- Others
GLOBAL PCR-BASED INFECTIOUS DISEASES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Clinical diagnostics
- Research applications
- Epidemiological studies
GLOBAL PCR-BASED INFECTIOUS DISEASES MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032
- Hospitals & Clinics
- Diagnostic Laboratories
- Research Institutes
- Pharmaceutical & Biotechnology Companies
GLOBAL PCR-BASED INFECTIOUS DISEASES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- Traditional PCR
- Real-time PCR (qPCR)
- Digital PCR (dPCR)
- Reverse Transcriptase PCR (RT-PCR)
- Nested PCR
- Multiplex PCR
GLOBAL PCR-BASED INFECTIOUS DISEASES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Product Code: ANV2930
Table of Contents
1. PCR-based Infectious Diseases Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. PCR-based Infectious Diseases Market Snippet by Disease Type
- 2.1.2. PCR-based Infectious Diseases Market Snippet by Application
- 2.1.3. PCR-based Infectious Diseases Market Snippet by End User
- 2.1.4. PCR-based Infectious Diseases Market Snippet by Technology
- 2.1.5. PCR-based Infectious Diseases Market Snippet by Country
- 2.1.6. PCR-based Infectious Diseases Market Snippet by Region
- 2.2. Competitive Insights
3. PCR-based Infectious Diseases Key Market Trends
- 3.1. PCR-based Infectious Diseases Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. PCR-based Infectious Diseases Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. PCR-based Infectious Diseases Market Opportunities
- 3.4. PCR-based Infectious Diseases Market Future Trends
4. PCR-based Infectious Diseases Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. PCR-based Infectious Diseases Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. PCR-based Infectious Diseases Market Landscape
- 6.1. PCR-based Infectious Diseases Market Share Analysis, 2023
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. PCR-based Infectious Diseases Market - By Disease Type
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Disease Type, 2023 & 2032 (%)
- 7.1.2. Viral diseases
- 7.1.2.1. HIV
- 7.1.2.2. hepatitis
- 7.1.2.3. influenza
- 7.1.3. Bacterial diseases
- 7.1.3.1. tuberculosis
- 7.1.3.2. MRSA
- 7.1.4. Fungal infections
- 7.1.4.1. candidiasis
- 7.1.5. Parasitic infections
- 7.1.6. Others
8. PCR-based Infectious Diseases Market - By Application
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
- 8.1.2. Clinical diagnostics
- 8.1.3. Research applications
- 8.1.4. Epidemiological studies
9. PCR-based Infectious Diseases Market - By End User
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
- 9.1.2. Hospitals & Clinics
- 9.1.3. Diagnostic Laboratories
- 9.1.4. Research Institutes
- 9.1.5. Pharmaceutical & Biotechnology Companies
10. PCR-based Infectious Diseases Market - By Technology
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
- 10.1.2. Traditional PCR
- 10.1.3. Real-time PCR (qPCR)
- 10.1.4. Digital PCR (dPCR)
- 10.1.5. Reverse Transcriptase PCR (RT-PCR)
- 10.1.6. Nested PCR
- 10.1.7. Multiplex PCR
11. PCR-based Infectious Diseases Market- By Geography
- 11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
- 11.2. North America
- 11.2.1. Overview
- 11.2.2. PCR-based Infectious Diseases Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
- 11.2.8.1. Overview
- 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.2.8.3. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.2.8.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.8.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.2.8.6. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
- 11.2.9.1. Overview
- 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.2.9.3. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.2.9.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.9.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.2.9.6. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3. Europe
- 11.3.1. Overview
- 11.3.2. PCR-based Infectious Diseases Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
- 11.3.8.1. Overview
- 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.8.3. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.3.8.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.8.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.8.6. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.9. Italy
- 11.3.9.1. Overview
- 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.9.3. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.3.9.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.9.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.9.6. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.10. United Kingdom
- 11.3.10.1. Overview
- 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.10.3. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.3.10.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.10.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.10.6. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.11. France
- 11.3.11.1. Overview
- 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.11.3. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.3.11.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.11.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.11.6. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.12. Russia
- 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.12.2. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.3.12.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.12.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.12.5. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.13. Netherlands
- 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.13.2. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.3.13.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.13.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.13.5. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
- 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.14.2. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.3.14.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.14.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.14.5. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.15. Poland
- 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.15.2. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.3.15.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.15.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.15.5. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.3.16. Rest of Europe
- 11.3.16.1. Overview
- 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.3.16.3. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.3.16.6. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. PCR-based Infectious Diseases Key Manufacturers in Asia Pacific
- 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.7. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.8. India
- 11.4.8.1. Overview
- 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.8.3. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.8.6. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.9. China
- 11.4.9.1. Overview
- 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.9.3. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.4.9.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.9.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.9.6. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
- 11.4.10.1. Overview
- 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.10.3. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.4.10.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.10.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.10.6. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
- 11.4.11.1. Overview
- 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.11.3. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.4.11.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.11.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.11.6. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
- 11.4.12.1. Overview
- 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.12.3. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.4.12.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.12.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.12.6. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.13. Thailand
- 11.4.13.1. Overview
- 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.13.3. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.13.6. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.14. Indonesia
- 11.4.14.1. Overview
- 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.14.3. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.4.14.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.14.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.14.6. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
- 11.4.15.1. Overview
- 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.15.3. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.4.15.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.15.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.15.6. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
- 11.4.16.1. Overview
- 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.4.16.3. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.4.16.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.16.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.4.16.6. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.5. Latin America
- 11.5.1. Overview
- 11.5.2. PCR-based Infectious Diseases Key Manufacturers in Latin America
- 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.7. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
- 11.5.8.1. Overview
- 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.8.3. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.5.8.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.8.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.8.6. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
- 11.5.9.1. Overview
- 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.9.3. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.5.9.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.9.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.9.6. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
- 11.5.10.1. Overview
- 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.10.3. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.5.10.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.10.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.10.6. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
- 11.5.11.1. Overview
- 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.11.3. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.5.11.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.11.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.11.6. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
- 11.5.12.1. Overview
- 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.5.12.3. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.12.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.5.12.6. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6. Middle East and Africa
- 11.6.1. Overview
- 11.6.2. PCR-based Infectious Diseases Key Manufacturers in Middle East and Africa
- 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.7. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
- 11.6.8.1. Overview
- 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.8.3. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.8.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.8.6. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
- 11.6.9.1. Overview
- 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.9.3. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.9.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.9.6. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
- 11.6.10.1. Overview
- 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.10.3. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.6.10.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.10.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.10.6. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
- 11.6.11.1. Overview
- 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.11.3. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.6.11.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.11.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.11.6. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
- 11.6.12.1. Overview
- 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.12.3. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.6.12.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.12.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.12.6. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
- 11.6.13.1. Overview
- 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.13.3. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.6.13.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.13.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.13.6. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
- 11.6.14.1. Overview
- 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 11.6.14.3. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
- 11.6.14.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.14.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 11.6.14.6. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- PCR-based Infectious Diseases Industry
- 12.1. Competitive Dashboard
- 12.2. Company Profiles
- 12.2.1. Abbott Laboratories
- 12.2.2. Takara Bio, Inc
- 12.2.3. Thermo Fisher Scientific
- 12.2.4. Qiagen N.V.
- 12.2.5. Bio-Rad Laboratories, Inc
- 12.2.6. Roche Diagnostics
- 12.2.7. Cepheid
- 12.2.8. DiaSorin
- 12.2.9. Others
13. 360 Degree Analyst View
14. Appendix
- 14.1. Research Methodology
- 14.2. References
- 14.3. Abbreviations
- 14.4. Disclaimer
- 14.5. Contact Us
Product Code: ANV2930
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE PCR-based Infectious Diseases Market: Disease Type Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Disease Type
- TABLE Global PCR-based Infectious Diseases Market, by Disease Type 2019-2032 (USD Million)
- TABLE PCR-based Infectious Diseases Market: Application Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Application
- TABLE Global PCR-based Infectious Diseases Market, by Application 2019-2032 (USD Million)
- TABLE PCR-based Infectious Diseases Market: End User Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by End User
- TABLE Global PCR-based Infectious Diseases Market, by End User 2019-2032 (USD Million)
- TABLE PCR-based Infectious Diseases Market: Technology Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Technology
- TABLE Global PCR-based Infectious Diseases Market, by Technology 2019-2032 (USD Million)
- TABLE PCR-based Infectious Diseases Market: Regional snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global PCR-based Infectious Diseases Market, by Region 2019-2032 (USD Million)
- TABLE North America PCR-based Infectious Diseases Market, by Country, 2019-2032 (USD Million)
- TABLE North America PCR-based Infectious Diseases Market, by Disease Type, 2019-2032 (USD Million)
- TABLE North America PCR-based Infectious Diseases Market, by Application, 2019-2032 (USD Million)
- TABLE North America PCR-based Infectious Diseases Market, by End User, 2019-2032 (USD Million)
- TABLE North America PCR-based Infectious Diseases Market, by Technology, 2019-2032 (USD Million)
- TABLE Europe PCR-based Infectious Diseases Market, by Country, 2019-2032 (USD Million)
- TABLE Europe PCR-based Infectious Diseases Market, by Disease Type, 2019-2032 (USD Million)
- TABLE Europe PCR-based Infectious Diseases Market, by Application, 2019-2032 (USD Million)
- TABLE Europe PCR-based Infectious Diseases Market, by End User, 2019-2032 (USD Million)
- TABLE Europe PCR-based Infectious Diseases Market, by Technology, 2019-2032 (USD Million)
- TABLE Asia Pacific PCR-based Infectious Diseases Market, by Country, 2019-2032 (USD Million)
- TABLE Asia Pacific PCR-based Infectious Diseases Market, by Disease Type, 2019-2032 (USD Million)
- TABLE Asia Pacific PCR-based Infectious Diseases Market, by Application, 2019-2032 (USD Million)
- TABLE Asia Pacific PCR-based Infectious Diseases Market, by End User, 2019-2032 (USD Million)
- TABLE Asia Pacific PCR-based Infectious Diseases Market, by Technology, 2019-2032 (USD Million)
- TABLE Latin America PCR-based Infectious Diseases Market, by Country, 2019-2032 (USD Million)
- TABLE Latin America PCR-based Infectious Diseases Market, by Disease Type, 2019-2032 (USD Million)
- TABLE Latin America PCR-based Infectious Diseases Market, by Application, 2019-2032 (USD Million)
- TABLE Latin America PCR-based Infectious Diseases Market, by End User, 2019-2032 (USD Million)
- TABLE Latin America PCR-based Infectious Diseases Market, by Technology, 2019-2032 (USD Million)
- TABLE Middle East and Africa PCR-based Infectious Diseases Market, by Country, 2019-2032 (USD Million)
- TABLE Middle East and Africa PCR-based Infectious Diseases Market, by Disease Type, 2019-2032 (USD Million)
- TABLE Middle East and Africa PCR-based Infectious Diseases Market, by Application, 2019-2032 (USD Million)
- TABLE Middle East and Africa PCR-based Infectious Diseases Market, by End User, 2019-2032 (USD Million)
- TABLE Middle East and Africa PCR-based Infectious Diseases Market, by Technology, 2019-2032 (USD Million)
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.